Specific Probiotic Therapy Attenuates Antibiotic Induced Visceral Hypersensitivity in Mice

Overview

Journal Gut

Specialty Gastroenterology

Date 2005 Aug 18

PMID 16105890

Citations 177

Authors

E F Verdu

P Bercik

M Verma-Gandhu

X-X Huang

P Blennerhassett

W Jackson

Y Mao

L Wang

F Rochat

S M Collins

Affiliations

Soon will be listed here.

Abstract

Background And Aims: Abdominal pain and discomfort are common symptoms in functional disorders and are attributed to visceral hypersensitivity. These symptoms fluctuate over time but the basis for this is unknown. Here we examine the impact of changes in gut flora and gut inflammatory cell activity on visceral sensitivity.

Methods: Visceral sensitivity to colorectal distension (CRD) was assessed at intervals in healthy mice for up to 12 weeks, and in mice before and after administration of dexamethasone or non-absorbable antibiotics with or without supplementation with Lactobacillus paracasei (NCC2461). Tissue was obtained for measurement of myeloperoxidase activity (MPO), histology, microbiota analysis, and substance P (SP) immunolabelling.

Results: Visceral hypersensitivity developed over time in healthy mice maintained without sterile precautions. This was accompanied by a small increase in MPO activity. Dexamethasone treatment normalised MPO and CRD responses. Antibiotic treatment perturbed gut flora, increased MPO and SP immunoreactivity in the colon, and produced visceral hypersensitivity. Administration of Lactobacillus paracasei in spent culture medium normalised visceral sensitivity and SP immunolabelling, but not intestinal microbiota counts.

Conclusion: Perturbations in gut flora and in inflammatory cell activity alter sensory neurotransmitter content in the colon, and result in altered visceral perception. Changes in gut flora may be a basis for the variability of abdominal symptoms observed in functional gastrointestinal disorders and may be prevented by specific probiotic administration.

Citing Articles

Microbiota-neuroepithelial signalling across the gut-brain axis.

Ohara T, Hsiao E Nat Rev Microbiol. 2025; .

PMID: 39743581 DOI: 10.1038/s41579-024-01136-9.

A pathophysiologic framework for the overlap of disorders of gut-brain interaction and the role of the gut microbiome.

Shah A, Lee Y, Suzuki H, Tan-Loh J, Siah K, Gwee K Gut Microbes. 2024; 16(1):2413367.

PMID: 39482844 PMC: 11540069. DOI: 10.1080/19490976.2024.2413367.

Microbiome contributions to pain: a review of the preclinical literature.

Pratt M, Plumb A, Manjrekar A, Cardona L, Chan C, John J Pain. 2024; 166(2):262-281.

PMID: 39258679 PMC: 11723818. DOI: 10.1097/j.pain.0000000000003376.

The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.

Wu Y, Li Y, Zheng Q, Li L Nutrients. 2024; 16(13).

PMID: 38999862 PMC: 11243554. DOI: 10.3390/nu16132114.

An examination of global research trends for exploring the associations between the gut microbiota and nonalcoholic fatty liver disease through bibliometric and visualization analysis.

Zyoud S, Alalalmeh S, Hegazi O, Shakhshir M, Abushamma F, Al-Jabi S Gut Pathog. 2024; 16(1):31.

PMID: 38961453 PMC: 11223324. DOI: 10.1186/s13099-024-00624-w.

References

Bercik P, Wang L, Verdu E, Mao Y, Blennerhassett P, Khan W . Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. Gastroenterology. 2004; 127(1):179-87. DOI: 10.1053/j.gastro.2004.04.006. View

Piedimonte G, Rodriguez M, King K, McLean S, Jiang X . Respiratory syncytial virus upregulates expression of the substance P receptor in rat lungs. Am J Physiol. 1999; 277(4):L831-40. DOI: 10.1152/ajplung.1999.277.4.L831. View

Pimentel M, Chow E, Lin H . Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol. 2001; 95(12):3503-6. DOI: 10.1111/j.1572-0241.2000.03368.x. View

Hooper L, Wong M, Thelin A, Hansson L, Falk P, Gordon J . Molecular analysis of commensal host-microbial relationships in the intestine. Science. 2001; 291(5505):881-4. DOI: 10.1126/science.291.5505.881. View

Barbara G, De Giorgio R, Deng Y, Vallance B, Blennerhassett P, Collins S . Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice. Gastroenterology. 2001; 120(7):1729-36. DOI: 10.1053/gast.2001.24847. View

Schneider J, Jehle E, Starlinger M, Neunlist M, Michel K, Hoppe S . Neurotransmitter coding of enteric neurones in the submucous plexus is changed in non-inflamed rectum of patients with Crohn's disease. Neurogastroenterol Motil. 2001; 13(3):255-64. DOI: 10.1046/j.1365-2982.2001.00265.x. View

Agreus L, Svardsudd K, Talley N, Jones M, Tibblin G . Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol. 2001; 96(10):2905-14. DOI: 10.1111/j.1572-0241.2001.04680.x. View

Collins S, Piche T, Rampal P . The putative role of inflammation in the irritable bowel syndrome. Gut. 2001; 49(6):743-5. PMC: 1728553. DOI: 10.1136/gut.49.6.743. View

Maxwell P, Rink E, Kumar D, Mendall M . Antibiotics increase functional abdominal symptoms. Am J Gastroenterol. 2002; 97(1):104-8. DOI: 10.1111/j.1572-0241.2002.05428.x. View

10.

Chadwick V, Chen W, Shu D, Paulus B, Bethwaite P, Tie A . Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology. 2002; 122(7):1778-83. DOI: 10.1053/gast.2002.33579. View

11.

Verdu E, Deng Y, Bercik P, Collins S . Modulatory effects of estrogen in two murine models of experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2002; 283(1):G27-36. DOI: 10.1152/ajpgi.00460.2001. View

12.

Madden J, Hunter J . A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br J Nutr. 2002; 88 Suppl 1:S67-72. DOI: 10.1079/BJN2002631. View

13.

Guarner F, Malagelada J . Gut flora in health and disease. Lancet. 2003; 361(9356):512-9. DOI: 10.1016/S0140-6736(03)12489-0. View

14.

Spiller R . Postinfectious irritable bowel syndrome. Gastroenterology. 2003; 124(6):1662-71. DOI: 10.1016/s0016-5085(03)00324-x. View

15.

Richard Locke 3rd G . Natural history of irritable bowel syndrome and durability of the diagnosis. Rev Gastroenterol Disord. 2003; 3 Suppl 3:S12-7. View

16.

Huerta C, Rodriguez L, Wallander M, Johansson S . Users of oral steroids are at a reduced risk of developing irritable bowel syndrome. Pharmacoepidemiol Drug Saf. 2003; 12(7):583-8. DOI: 10.1002/pds.836. View

17.

Gonkowski S, Kaminska B, Bossowska A, Korzon M, Landowski P, Majewski M . The influence of experimental Bacteroides fragilis infection on substance P and somatostatin-immunoreactive neural elements in the porcine ascending colon - a preliminary report. Folia Morphol (Warsz). 2003; 62(4):455-7. View

18.

Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, Rudensky B . Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology. 2004; 126(2):520-8. DOI: 10.1053/j.gastro.2003.11.019. View

19.

Kamm K, Hoppe S, Breves G, Schroder B, Schemann M . Effects of the probiotic yeast Saccharomyces boulardii on the neurochemistry of myenteric neurones in pig jejunum. Neurogastroenterol Motil. 2004; 16(1):53-60. DOI: 10.1046/j.1365-2982.2003.00458.x. View

20.

Barron R, Benoliel R, Zeltser R, Eliav E, Nahlieli O, Gracely R . Effect of dexamethasone and dipyrone on lingual and inferior alveolar nerve hypersensitivity following third molar extractions: preliminary report. J Orofac Pain. 2004; 18(1):62-8. View